Amphastar Pharmaceuticals Inc (AMPH)
42.39
+1.09
(+2.64%)
USD |
NASDAQ |
May 15, 15:24
Amphastar Pharmaceuticals Cash from Investing (TTM): -627.55M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -627.55M |
December 31, 2023 | -649.12M |
September 30, 2023 | -546.30M |
June 30, 2023 | -530.40M |
March 31, 2023 | -30.00M |
December 31, 2022 | -32.78M |
September 30, 2022 | -44.50M |
June 30, 2022 | -33.01M |
March 31, 2022 | -29.09M |
December 31, 2021 | -28.67M |
September 30, 2021 | -28.89M |
June 30, 2021 | -30.58M |
March 31, 2021 | -36.39M |
December 31, 2020 | -36.42M |
September 30, 2020 | -31.59M |
June 30, 2020 | -44.76M |
March 31, 2020 | -44.36M |
December 31, 2019 | -50.53M |
September 30, 2019 | -51.97M |
June 30, 2019 | -46.23M |
March 31, 2019 | -48.33M |
Date | Value |
---|---|
December 31, 2018 | -42.18M |
September 30, 2018 | -43.51M |
June 30, 2018 | -43.61M |
March 31, 2018 | -39.66M |
December 31, 2017 | -36.89M |
September 30, 2017 | -33.87M |
June 30, 2017 | -35.87M |
March 31, 2017 | -36.05M |
December 31, 2016 | -39.50M |
September 30, 2016 | -36.85M |
June 30, 2016 | -25.59M |
March 31, 2016 | -21.30M |
December 31, 2015 | -16.92M |
September 30, 2015 | -22.39M |
June 30, 2015 | -21.82M |
March 31, 2015 | -40.02M |
December 31, 2014 | -39.77M |
September 30, 2014 | -33.01M |
June 30, 2014 | -34.96M |
March 31, 2014 | -15.97M |
December 31, 2013 | -18.30M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-649.12M
Minimum
Dec 2023
-28.67M
Maximum
Dec 2021
-147.66M
Average
-40.39M
Median
Cash from Investing (TTM) Benchmarks
Eli Lilly and Co | -7.642B |
Dentsply Sirona Inc | -95.00M |
Pacira BioSciences Inc | -4.172M |
Corvus Pharmaceuticals Inc | 10.93M |
Organon & Co | -302.00M |